In an era marked by groundbreaking advancements in genomics sequencing and precision medicine, Illumina Intercontinental is playing a pivotal role. With its cutting-edge next-generation sequencing (NGS) technologies and global presence, Illumina continues to revolutionize the field of genomics.At th
Medtronic said it has entered into definitive agreements to acquire EOFlow, a Korean company specializing in wearable insulin pumps, and announced its intention to delist the company from the tech-heavy Kosdaq market.Under the definitive agreements, Medtronic will acquire all of the shares held by t
Samyang Holdings Corp. said it has signed a partnership agreement with Hangzhou Yxintent, a Chinese medical device and aesthetics company, for the export of Lafullen, a polycaprolactone (PCL)‐based filler.Lafullen is a filler for facial plastic surgery developed by Samyang Holdings. It is composed o
HanAll Biopharma and Daewoong Pharmaceutical said that they have entered into a joint research and development agreement with Boston-based preclinical biopharmaceutical company NurrOn Pharmaceuticals to develop treatments for Parkinson's disease and other neurodegenerative diseases.Under the agreeme
Samsung Medical Center (SMC) has suffered a major setback, being the first of the nation's five largest tertiary hospitals to be excluded from the government's top-tier ranking in the medical quality assessment, a local news report said.According to Chosun Ilbo, a vernacular newspaper, this is the f
The government's upcoming launch of a telemedicine pilot program next month has sparked intense criticism from various stakeholders, including the medical community, civic groups, and industry associations, for all different reasons.On May 17, the government released the direction for the pilot proj
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
The Korea Health Industry Development Institute (KHIDI) said it is recruiting trainees for the 2023 class of the Medical Korea Academy e-class (MKA e-class), an online medical training course for healthcare professionals in other countries.The session aims to promote Korean medical excellence and ex
Amid the mounting anticipation for the BIO International Convention 2023, Korean contract development and manufacturing organization (CDMO) companies are strategically positioning themselves to reinforce their stature as global frontrunners in the industry.According to industry officials, Samsung Bi
Competition in the Korean shingles vaccine market has reignited this year with the launch of GSK's Shingrix.According to IQVIA, a drug market research firm, the local shingles vaccine market grew from 10.5 billion won ($8 million) in the fourth quarter of last year to 21.8 billion won in the first q
Two Korean-made treatments, Rolvedon by Hanmi Pharm for neutropenia and Xcopri by SK Biopharmaceuticals for epilepsy, have shown significant sales growth in the first quarter in the U.S.According to Hanmi, Rolvedon posted sales of $15.62 million (20.8 billion won) in the U.S. in the first three mont
The National Cancer Center (NCC) has announced its plans to conduct an invitational training program, designed specifically for healthcare professionals from Côte d'Ivoire.The program's primary aim is to provide these professionals with in-depth knowledge and expertise in Korean cancer management pr
Merz Aesthetics said it recently held the "Confidence To Be" festival at COEX, Seoul, on May 13.According to the company, the festival was designed to directly communicate the meaning of Merz's global "Confidence To Be" campaign to Korean consumers, offering them the opportunity to experience a vari
The number of mpox cases in Korea increased by six from last Tuesday to Monday, bringing the total number of confirmed cases to 81.Except for five cases, the 76 cases have been confirmed since April 4, with Korea confirming 34 cases in May alone.Even though the World Health Organization (WHO) lifted
Exports made by the Korean healthcare industry have declined almost 25 percent in the first quarter compared to a year earlier due to the low demand for Covid-19-related treatments and diagnostic devices.According to the Korea Health Industry Development Institute (KHIDI), healthcare exports in the
Companies under Hyundai Group and Hyundai Motor Group -- such as Hyundai Mobis, Hyundai Department Store, Hyundai Motor, and HD Hyundai -- are actively expanding their healthcare business by entering diverse sectors, including digital healthcare, health functional foods, and medical robots.Most rece
HanAll Biopharma announced that the U.S. phase 3 clinical trial (VELOS-3) of HL036 (ingredient: tanfanercept), a promising drug candidate for dry eye disease, did not yield statistically significant results for the primary endpoint.HL036 is a biologic drug jointly developed by HanAll Biopharma and D
Osstem Implant, a Korean dental equipment and supplies manufacturer, confirmed its intention to voluntarily delist from the tech-heavy Kosdaq market.The company said in a public filing on Thursday that it would hold an extraordinary general shareholders’ meeting regarding the delisting issue at its
Similar to other Asian nations grappling with declining birth rates, Singapore experienced a record-low total birth rate of 1.05 in 2022, surpassing the previous records of 1.1 in 2020 and 1.12 in 2021.Singapore's low birth rate remains a pressing demographic concern, posing challenges to its aging
Using single-cell analysis, a research team at St. Mary's Seoul Hospital has unveiled the cellular interactions, gene expression, and distinctive features of immune tolerance following kidney transplantation.Kidney transplantation is considered the most ideal treatment for end-stage renal disease pa